Journal of Neurology & Neurophysiology

Risk of Thromboembolism in Patients Suffering from Multiple Sclerosis

Arpaia G, Bavera P, Ippolito E, Spezzigu G, Agus GB and Cimminiello C

DOI: 10.4172/2155-9562.S12-002

The Clinical Course of Multiple Sclerosis Needs to be Redefined in the Treatment Era of MS

Thomas F Scott

DOI: 10.4172/2155-9562.S12-003

Metabolic Control of Th17 Cell Generation and CNS Inflammation

Kai Yang and Hongbo Chi

DOI: 10.4172/2155-9562.S12-004

The Effect of Methylprednisolone, Interferon Beta and Glatiramer Acetate Treatment on the Levels of Leptin, Adiponectin and Resistin in Multiple Sclerosis Patients

Slawomir Michalak, Lukasz Jernas, Ewa Wysocka, Krystyna Osztynowicz, Elzbieta Tokarz-Kupczyk, Halina Wygladalska-Jernas and Wojciech Kozubski

DOI: 10.4172/2155-9562.S12-005

Tumefactive Demyelinating Lesions in Patients with Relapsing Remitting Multiple Sclerosis Treated with Fingolimod

Rocco Totaro, Caterina Di Carmine and Antonio Carolei

DOI: 10.4172/2155-9562.S12-006

A Bibliometric Analysis of Optic Coherence Tomography Studies in Multiple Sclerosis

Nedim Ongun, Cagdas Erdogan and Eylem Degirmenci

DOI: 10.4172/2155-9562.S12-007

Melatonin and Multiple Sclerosis: An Outline on Current Evidences

Seyed-Hossein Abtahi, Zahra Nasr, Niloofaralsadat Nourian, Seyed-Mojtaba Abtahi, Fatemeh Abrishamchi, Masoud Etemadifar and Mahboobeh Fereidan-Esfahani

DOI: 10.4172/2155-9562.S12-008

ω-3 Polyunsaturated Fatty Acids on the Prognosis of Multiple Sclerosis: The Effect of Eicosapentaenoic acid

Serafina Salvati and Antonella Di Biase

DOI: 10.4172/2155-9562.S12-009